Travers Smith has advised longstanding client Inflexion on its investment in SteriPack Group, a market-leading global contract manufacturer serving the medical device, pharmaceutical and diagnostic markets.
Founded over 25 years ago in Ireland, SteriPack set out "to be the number one pain reliever for the world’s largest OEM & Pharmaceutical companies". Now operating across a global network of manufacturing facilities in Ireland, Poland, Malaysia and the US, the SteriPack Group employs over 650 and has over 100 clients, with a global reach extending to more than 50 countries.
Travers Smith has a strong recent track record in advising Inflexion on many high profile transactions, having also recently advised Inflexion on the £535m sale of Marley Group to FTSE250 listed Marshalls plc.
The Travers Smith team was led by Private Equity & Financial Sponsors Partner Will Yates and Senior Counsel Joanna Roberts, with support from Senior Associate Becky Dove, Associates Oisin Sudway, Sarah Owadally and Jarrett Whitehead. Tax advice was provided by Tax Partner Jessica Kemp and Senior Associate Joseph Sheldrick. Finance advice was provided by Finance Partner and Head of Leveraged Finance Matthew Ayre and Senior Associate Jason Larkins.
